Observational studyMedicine2025
The relationship between Oxidation Balance Score and all-cause mortality in patients with hypertension: An observational study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The Oxidation Balance Score (OBS), which integrates prooxidant and antioxidant exposures from diet and lifestyle, serves as an indicator of systemic oxidative stress. This study examined the association between OBS and all-cause mortality among U.S. adults with hypertension. OBS was derived from 16 dietary nutrients and 3 lifestyle factors. The nonlinear relationship between OBS and mortality was assessed using smoothing splines. Kaplan-Meier curves, multivariable Cox regression, competing risk models, and subgroup analyses were employed to evaluate mortality risks. The results from the smoothing spline plots and Kaplan-Meier curves suggested that higher OBS levels were associated with lower all-cause mortality. After full adjustment, the Cox regression model revealed that higher OBS levels were associated with a 13% reduction in the risk of all-cause mortality among patients with hypertension compared to those with lower OBS levels (hazard ratios = 0.87, 95% confidence interval: 0.78-0.96, P = .004; P for trend = .003). Sensitivity analysis confirmed a protective association between higher OBS and 10-year mortality, indicating a 13% reduction in risk (hazard ratios = 0.87, 95% confidence interval: 0.78-0.98, P = .019; P for trend = .017). Competing risk models further confirmed that higher OBS reduced hypertension-related mortality. A nonlinear relationship exists between OBS and all-cause mortality in patients with hypertension. Higher OBS is linked to lower mortality, suggesting its potential utility in the prognostic risk assessment for hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.